telotristat ethyl   Click here for help

GtoPdb Ligand ID: 9490

Synonyms: LX-1606 | LX1606 | Xermelo®
Approved drug Immunopharmacology Ligand
telotristat ethyl is an approved drug (FDA (2017))
Compound class: Synthetic organic
Comment: Telotristat ethyl is an oral tryptophan hydroxylase inhibitor. Telotristat ethyl is the USAN, the INN is telotristat (represented in PubChem CID 25025298.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 130.65
Molecular weight 574.17
XLogP 6
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCOC(=O)C(Cc1ccc(cc1)c1cc(nc(n1)N)OC(C(F)(F)F)c1ccc(cc1n1ccc(n1)C)Cl)N
Isomeric SMILES CCOC(=O)[C@H](Cc1ccc(cc1)c1cc(nc(n1)N)O[C@@H](C(F)(F)F)c1ccc(cc1n1ccc(n1)C)Cl)N
InChI InChI=1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1
InChI Key MDSQOJYHHZBZKA-GBXCKJPGSA-N
References
1. Bae EJ, Choi WG, Pagire HS, Pagire SH, Parameswaran S, Choi JH, Yoon J, Choi WI, Lee JH, Song JS et al.. (2021)
Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.
J Med Chem, 64 (2): 1037-1053. [PMID:33417443]
2. Kim JJ, Wang H, Terc JD, Zambrowicz B, Yang QM, Khan WI. (2015)
Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation.
Am J Physiol Gastrointest Liver Physiol, 309 (6): G455-65. [PMID:26206858]
3. Kulke MH, Hörsch D, Caplin ME, Anthony LB, Bergsland E, Öberg K, Welin S, Warner RR, Lombard-Bohas C, Kunz PL et al.. (2017)
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.
J Clin Oncol, 35 (1): 14-23. [PMID:27918724]
4. Lamarca A, Barriuso J, McNamara MG, Hubner RA, Valle JW. (2016)
Telotristat ethyl: a new option for the management of carcinoid syndrome.
Expert Opin Pharmacother, 17 (18): 2487-2498. [PMID:27817224]
5. Margolis KG, Stevanovic K, Li Z, Yang QM, Oravecz T, Zambrowicz B, Jhaver KG, Diacou A, Gershon MD. (2014)
Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.
Gut, 63 (6): 928-37. [PMID:23749550]